Y-mAbs to Present at the Oppenheimer 35th Annual Life Sciences Conference

Y-mAbs TherapeuticsFeb 6 00:00 ET

Little Excitement Around Y-mAbs Therapeutics, Inc.'s (NASDAQ:YMAB) Revenues As Shares Take 27% Pounding

Simply Wall StFeb 2 08:43 ET

Y-mAbs Therapeutics Presents Preclinical Data on GD2-SADA at SNMMI/ACNM Annual Meeting

Quiver QuantitativeJan 31 07:40 ET

Express News | Y-mAbs Presents Translational Pharmacokinetics of GD2-Sada From Pretargeted Rit Platform at the Snmmi Mid-Winter and Acnm Annual Meeting

ReutersJan 31 07:35 ET

Y-mAbs Presents Translational Pharmacokinetics of GD2-SADA From Pretargeted RIT Platform at the SNMMI Mid-Winter and ACNM Annual Meeting

Y-mAbs TherapeuticsJan 31 00:00 ET

Insiders Could Have Profited By Holding Onto Y-mAbs Therapeutics Shares Despite 16% Drop

Simply Wall StJan 17 07:22 ET